Catalyst Pharma Appoints Richard Daly To Succeed Patrick McEnany As CEO

RTTNews | 587 dni temu
Catalyst Pharma Appoints Richard Daly To Succeed Patrick McEnany As CEO

(RTTNews) - Biopharmaceutical company Catalyst Pharmaceuticals, Inc. (CPRX) announced Thursday the appointment of Richard Daly as its new Chief Executive Officer, effective January 1, 2024. Daly is a seasoned pharmaceutical executive bringing more than three decades of experience to Catalyst.

In order to facilitate an orderly transition, Patrick McEnany, Founder, Chairman, and CEO, will retire from the CEO position effective December 31, 2023, and at that time will continue in his role as Chairman of the Board.

Prior to his appointment at Catalyst, Daly served as President of CARsgen Therapeutics Corp. since January 2022. Previously, he served as Chief Operating Officer at Beyond Springs Inc. from 2018 to 2022 and as CEO, President, and Chairman of Neuralstem, Inc. Throughout his career, Daly has held prominent leadership positions at leading global pharmaceutical companies, including serving as President of AstraZeneca's U.S. diabetes subsidiary.

Earlier, Daly served at Takeda and TAP Pharmaceuticals, a joint venture established between Takeda and Abbott Laboratories, where he held several senior leadership positions, including the Executive Vice President at Takeda Pharmaceutical North America and the Senior Vice President of Marketing at TAP Pharmaceuticals.

Daly has served on Catalyst's Board of Directors since February 2015 and will continue to serve on the board as the newly appointed CEO.

read more
Catalyst Pharma Says FIRDAPSE NDA Submitted In Japan By Partner DyDo Pharma

Catalyst Pharma Says FIRDAPSE NDA Submitted In Japan By Partner DyDo Pharma

Biopharmaceutical company Catalyst Pharmaceuticals, Inc. (CPRX) announced Monday that its collaboration partner, Japan's DyDo Pharma, Inc., reported that it has submitted a New Drug Application (NDA) to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, seeking marketing approval for FIRDAPSE (amifampridine) Tablets 10 mg for the treatment of Lambert Eaton myasthenic syndrome (LEMS) in Japan.
RTTNews | 527 dni temu
Kingfisher Q1 Sales Rise, Says Confident Of FY25 View; But Stock Down

Kingfisher Q1 Sales Rise, Says Confident Of FY25 View; But Stock Down

Home improvement retailer Kingfisher Plc reported Wednesday higher sales in its first quarter, benefited by improved results in UK & Ireland. Meanwhile, sales in France and Poland declined, and the company maintained its fiscal 2025 outlook. On the London Stock Exchange, Kingfisher shares were losing around 3.5 percent.
RTTNews | 2g 14 minut temu
Bay Street Likely To Open On Mixed Note

Bay Street Likely To Open On Mixed Note

Canadian shares are likely to open on a mixed note Wednesday morning with investors tracking global cues and reacting to earnings from major Canadian banks. Investors are also awaiting earnings update from U.S.
RTTNews | 2g 27 minut temu
FTSE 100 Down Marginally

FTSE 100 Down Marginally

UK stocks are marginally down in lackluster trade on Wednesday as investors look for directional clues after recent gains following U.S. President Donald Trump deciding to pause the recently announced 50% tariffs on imports from EU, paving the way for further trade negotiations.
RTTNews | 3g 16 minut temu
German Unemployment Rises More Than Expected

German Unemployment Rises More Than Expected

Joblessness in Germany increased more than expected in May as a weak economy continued to impede job creation, official data revealed on Wednesday. The number of unemployed increased sharply by 34,000 in May compared to April's rise of 6,000, the Federal Employment Agency said. Economists expected a monthly increase of 12,000.
RTTNews | 3g 20 minut temu
CAC 40 Down Marginally In Lackluster Trade

CAC 40 Down Marginally In Lackluster Trade

French stocks are moving in a tight range in cautious trade on Wednesday as investors digest a slew of domestic economic reports, and continue to assess the impact of Trump administration's trade policy on global economic growth.
RTTNews | 4g 29 minut temu
DAX Modestly Lower In Cautious Trade

DAX Modestly Lower In Cautious Trade

German stocks are modestly lower on Wednesday with investors mostly making cautious moves, looking for directional clues after recent gains on the back of U.S. President Donald Trump's decision to pause tariffs on EU goods till July 9th.
RTTNews | 4g 57 minut temu